235 related articles for article (PubMed ID: 30304852)
1. ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis.
Hlavničková M; Kuchař M; Osička R; Vaňková L; Petroková H; Malý M; Černý J; Arenberger P; Malý P
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304852
[TBL] [Abstract][Full Text] [Related]
2. p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells.
Křížová L; Kuchař M; Petroková H; Osička R; Hlavničková M; Pelák O; Černý J; Kalina T; Malý P
Autoimmunity; 2017 Mar; 50(2):102-113. PubMed ID: 28100093
[TBL] [Abstract][Full Text] [Related]
3. Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells.
Kuchař M; Vaňková L; Petroková H; Cerný J; Osička R; Pelák O; Sípová H; Schneider B; Homola J; Sebo P; Kalina T; Malý P
Proteins; 2014 Jun; 82(6):975-89. PubMed ID: 24549990
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel immunopharmacological ligands targeting the IL-17 inflammatory pathway.
Álvarez-Coiradas E; Munteanu CR; Díaz-Sáez L; Pazos A; Huber KVM; Loza MI; Domínguez E
Int Immunopharmacol; 2020 Dec; 89(Pt A):107026. PubMed ID: 33045560
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.
Krstic J; Obradovic H; Kukolj T; Mojsilovic S; Okic-Dordevic I; Bugarski D; Santibanez JF
Protein Pept Lett; 2015; 22(7):570-8. PubMed ID: 25990083
[TBL] [Abstract][Full Text] [Related]
6. Involvement of corneal epithelial cells in the Th17 response in an in vitro bacterial inflammation model.
Arranz-Valsero I; Schulze U; Contreras-Ruiz L; García-Posadas L; López-García A; Paulsen F; Diebold Y
Mol Vis; 2013; 19():85-99. PubMed ID: 23378722
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling and rational design of disulfide-stapled self-inhibitory peptides to target IL-17A/IL-17RA interaction.
Huang W; Zhou Y; Pan C; Zhang X; Zhao H; Shen L
J Mol Recognit; 2023 Aug; 36(8):e3045. PubMed ID: 37415317
[TBL] [Abstract][Full Text] [Related]
8. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties.
Goepfert A; Lehmann S; Wirth E; Rondeau JM
Sci Rep; 2017 Aug; 7(1):8906. PubMed ID: 28827714
[TBL] [Abstract][Full Text] [Related]
9. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex.
Wright JF; Bennett F; Li B; Brooks J; Luxenberg DP; Whitters MJ; Tomkinson KN; Fitz LJ; Wolfman NM; Collins M; Dunussi-Joannopoulos K; Chatterjee-Kishore M; Carreno BM
J Immunol; 2008 Aug; 181(4):2799-805. PubMed ID: 18684971
[TBL] [Abstract][Full Text] [Related]
10. Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling.
Zhang B; Liu C; Qian W; Han Y; Li X; Deng J
Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1476-83. PubMed ID: 24816115
[TBL] [Abstract][Full Text] [Related]
11. SELEX-discovered aptamer that inhibits cellular interleukin-17/interleukin-17 receptor interaction and antagonizes interleukin-17 signaling.
Munshi AR; Wang T; Takamori Y; Ando T; Yokoyama T; Fuji D; Xu Z; Vedi S; Yamamoto M; Tsukamoto K; Kawakami T
Biosci Biotechnol Biochem; 2024 Jan; 88(2):147-153. PubMed ID: 38031342
[TBL] [Abstract][Full Text] [Related]
12. Directed evolution of a soluble human IL-17A receptor for the inhibition of psoriasis plaque formation in a mouse model.
Zaretsky M; Etzyoni R; Kaye J; Sklair-Tavron L; Aharoni A
Chem Biol; 2013 Feb; 20(2):202-11. PubMed ID: 23438749
[TBL] [Abstract][Full Text] [Related]
13. Secretion and surface display of binders of IL-23/IL-17 cytokines and their receptors in Lactococcus lactis as a therapeutic approach against inflammation.
Plavec TV; Klemenčič K; Kuchař M; Malý P; Berlec A
Eur J Pharm Sci; 2023 Nov; 190():106568. PubMed ID: 37619953
[TBL] [Abstract][Full Text] [Related]
14. Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice.
Lo HY; Li CC; Cheng HM; Liu IC; Ho TY; Hsiang CY
Food Chem Toxicol; 2019 Jul; 129():365-375. PubMed ID: 31054998
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of interleukin 17A and its complex with IL-17 receptor A.
Liu S; Song X; Chrunyk BA; Shanker S; Hoth LR; Marr ES; Griffor MC
Nat Commun; 2013; 4():1888. PubMed ID: 23695682
[TBL] [Abstract][Full Text] [Related]
16. Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.
Goepfert A; Lehmann S; Blank J; Kolbinger F; Rondeau JM
Immunity; 2020 Mar; 52(3):499-512.e5. PubMed ID: 32187518
[TBL] [Abstract][Full Text] [Related]
17. p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin.
Škrlec K; Zadravec P; Hlavničková M; Kuchař M; Vaňková L; Petroková H; Křížová L; Černý J; Berlec A; Malý P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29966384
[TBL] [Abstract][Full Text] [Related]
18. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
19. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.
Kuestner RE; Taft DW; Haran A; Brandt CS; Brender T; Lum K; Harder B; Okada S; Ostrander CD; Kreindler JL; Aujla SJ; Reardon B; Moore M; Shea P; Schreckhise R; Bukowski TR; Presnell S; Guerra-Lewis P; Parrish-Novak J; Ellsworth JL; Jaspers S; Lewis KE; Appleby M; Kolls JK; Rixon M; West JW; Gao Z; Levin SD
J Immunol; 2007 Oct; 179(8):5462-73. PubMed ID: 17911633
[TBL] [Abstract][Full Text] [Related]
20. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
Srikanth M; Rasool M
Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
